Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Celsion Corporation (CLSN)

« Back to company index

CLSN Chatter Timeline

Stock Ticker for CLSN

Most Active Tweeters for CLSN

No tweets found

Recent Tweets for CLSN

WatchlistN @WatchlistN
Analyzing Celsion $CLSN and Achaogen $AKAO https://t.co/eGF3M7Lt62
August 21st 2018, 8:08pm
Markfor65836606 @Markfor65836606
$CLSN I am frustrated by this delay in Gen 1 as well but at this point it’s old news. Market gave a modest haircut and OM reiterated at $9.
August 21st 2018, 6:08pm
top10stocksof21 @top10stocksof21
Celsion Corp. $CLSN Stock Live Analysis 03-15-2017 #nasdaq https://t.co/HuLo23rXqv
August 21st 2018, 11:08am
ZolmaxNews @ZolmaxNews
Celsion $CLSN Downgraded to Sell at Zacks Investment Research https://t.co/IwJmv0e65j
August 21st 2018, 9:08am
TranscriptDaily @TranscriptDaily
Equities Analysts Set Expectations for Celsion Co.’s Q3 2018 Earnings $CLSN https://t.co/ZhY8fcBo6D
August 21st 2018, 5:08am
bigbluecup721 @bigbluecup721
Celsion Corp. $CLSN Stock Live Analysis 10-12-2017 #stockmarket https://t.co/LR6EqcmJIX
August 20th 2018, 10:08pm
ConsumerFeed @ConsumerFeed
Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/TdS4grFpvt
August 20th 2018, 7:08pm
registrarjourn @registrarjourn
Celsion $CLSN Receiving Somewhat Favorable Press Coverage, Accern Reports https://t.co/I1iuYx5Wmb
August 20th 2018, 7:08pm
EnterpriseLeade @EnterpriseLeade
Celsion $CLSN Receiving Somewhat Favorable Press Coverage, Accern Reports https://t.co/xBnPgmWY9o
August 20th 2018, 7:08pm
MareaInformativ @MareaInformativ
Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/xkueNwc65N
August 20th 2018, 6:08am
AmericanBanking @AmericanBanking
Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/RAtlgBKm8o #stocks
August 20th 2018, 1:08am
ConsumerFeed @ConsumerFeed
Celsion Co. $CLSN Expected to Earn Q3 2018 Earnings of -$0.42 Per Share https://t.co/wkGN1xR4A9
August 20th 2018, 1:08am
ChartMill @ChartMill
$CLSN shows a strong growth in EPS: 78.11%. https://t.co/57G7442c3v https://t.co/DnSgReCkxm
August 19th 2018, 1:08pm
TranscriptDaily @TranscriptDaily
Celsion Co. $CLSN Expected to Post FY2022 Earnings of $1.40 Per Share https://t.co/1DBe7HKWho
August 18th 2018, 3:08am
registrarjourn @registrarjourn
Analysts Offer Predictions for Celsion Co.’s FY2022 Earnings $CLSN https://t.co/f1GsTWYBED
August 17th 2018, 6:08am
EnterpriseLeade @EnterpriseLeade
Analysts Offer Predictions for Celsion Co.’s FY2022 Earnings $CLSN https://t.co/cz3EwBCvcN
August 17th 2018, 6:08am
OlympiaReport @OlympiaReport
Celsion $CLSN Shares Down 9.4% on Disappointing Earnings https://t.co/VIxWrd0MVF
August 16th 2018, 5:08pm
WeekHerald @WeekHerald
Celsion $CLSN Shares Down 9.4% Following Weak Earnings https://t.co/TZyJCzw0uC
August 16th 2018, 5:08pm
dispatchtribune @dispatchtribune
Celsion $CLSN Stock Price Down 9.4% Following Weak Earnings https://t.co/BacnpwZZDb
August 16th 2018, 5:08pm
ZolmaxNews @ZolmaxNews
Celsion $CLSN Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS https://t.co/XyF8wSQcVM
August 16th 2018, 5:08pm
dailypoliticaln @dailypoliticaln
Celsion $CLSN Announces Earnings Results https://t.co/U5EePkG5Gh
August 16th 2018, 5:08pm
filing_scanner @filing_scanner
$CLSN New Insider Filing On: Fritz Frederick J. Transaction Code: P https://t.co/JDVgwKiXbr
August 16th 2018, 4:08pm
TickerReport @TickerReport
Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/frzg6QgKaV
August 16th 2018, 9:08am
AmericanBanking @AmericanBanking
Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/Bx4LLP7TUu #stocks
August 16th 2018, 9:08am
WatchlistN @WatchlistN
Oppenheimer Weighs in on Celsion Co.’s FY2022 Earnings $CLSN https://t.co/Blov9t8fDz
August 16th 2018, 9:08am
RatingsNetwork @RatingsNetwork
Oppenheimer Sets Celsion FY2022 Earnings Estimates at $1.40 EPS. https://t.co/cb9ZnQ0Y0l $CLSN #CLSN
August 16th 2018, 9:08am
InsiderAlertsIA @InsiderAlertsIA
$CLSN: New Insider Filing on Director FREDERICK J. FRITZ: https://t.co/510o1g4urw
August 15th 2018, 2:08pm
Allstocknews @Allstocknews
$CLSN New Form 4 for Celsion Corporation From our Stock News Alerts App
August 15th 2018, 2:08pm
StockTexts @StockTexts
$CLSN Celsion Corporation SEC Filing: Form 4 https://t.co/j6L0xh7tSk
August 15th 2018, 2:08pm
bret_jensen @bret_jensen
$CLSN $MOTS 2 Notable morning analyst calls amid the market sell-off early today...https://t.co/ccLW4pgd2T
August 15th 2018, 11:08am
SolarMelt @SolarMelt
$CLSN Bottom-Line: The mounting evidence clearly suggests that the combination of Thermodox plus either optimized R… https://t.co/f3sX773okC
August 14th 2018, 11:08pm
SolarMelt @SolarMelt
$CLSN Oxford University also tested Thermodox recently, but with focused ultrasound instead of RFA - less invasive.… https://t.co/4AELcRunnb
August 14th 2018, 11:08pm
SolarMelt @SolarMelt
$CLSN The NIH recently conducted a post hoc analysis on the HEAT data. Focusing on 437 single lesion patients, the… https://t.co/4ZY8zEdDJE
August 14th 2018, 11:08pm
SolarMelt @SolarMelt
$CLSN A recent Interim Analysis combining 411 patients from both arms of OPTIMA (RFA with and without ThermoDox) re… https://t.co/9cRJq5IqmN
August 14th 2018, 11:08pm
SolarMelt @SolarMelt
$CLSN ThermoDox (HCC) OPTIMA - P3 Interim Efficacy Analysis - Late 2Q19 In the prior P3 (HEAT) trial, a median OS w… https://t.co/bw5wc0Untc
August 14th 2018, 11:08pm
SolarMelt @SolarMelt
$CLSN Update GEN-1 (Ovarian Cancer) OVATION-I - P1b - Final PFS Data in 2H18 OVATION-II - P1/2 - Multiple Updates 4… https://t.co/Mw4c4kZoV3
August 14th 2018, 11:08pm
Markfor65836606 @Markfor65836606
$CLSN delay is incompetence and an indictment of management team. They have no idea what will happen with Gen1 or Thermodox.
August 14th 2018, 10:08pm
MareaInformativ @MareaInformativ
Celsion $CLSN Stock Price Down 9.4% https://t.co/GRF9plg6Ox
August 14th 2018, 9:08pm
bbnsnews @bbnsnews
Celsion $CLSN Shares Down 9.4% https://t.co/z9R5vgUe6x
August 14th 2018, 9:08pm
MareaInformativ @MareaInformativ
Celsion $CLSN Releases Earnings Results, Misses Expectations By $0.18 EPS https://t.co/qMRX4y6FL9
August 14th 2018, 12:08pm
dakotafinancial @dakotafinancial
Celsion $CLSN Releases Quarterly Earnings Results, Misses Expectations By $0.18 EPS https://t.co/YPpaD4AWe1
August 14th 2018, 11:08am
AmericanBanking @AmericanBanking
Celsion $CLSN Announces Earnings Results https://t.co/SsVVCAdUuW #stocks
August 14th 2018, 11:08am
ConsumerFeed @ConsumerFeed
Celsion $CLSN Posts Quarterly Earnings Results, Misses Expectations By $0.18 EPS https://t.co/CCqDhQd8i2
August 14th 2018, 11:08am
earningscast @earningscast
$CLSN Listen to Q2 2018 Celsion Corporat Earnings Call (EPS -0.46 vs EST -0.27) live at 11:00 AM,ondemand after https://t.co/D0XDsNlihZ
August 14th 2018, 10:08am
investornetwork @investornetwork
#InvestorEvent $CLSN to host Q2 Earnings Call TODAY at 11am Eastern! Stream LIVE or on Replay at https://t.co/09tBdcsM6p
August 14th 2018, 10:08am
StockNewsNow @StockNewsNow
$CLSN Celsion Corporation Reports Second Quarter 2018 Financial Results and Provides Business Update https://t.co/MwsVAZlT8P
August 14th 2018, 10:08am
Allstocknews @Allstocknews
$CLSN New Form 10-Q for Celsion Corporation From our Stock News Alerts App
August 14th 2018, 9:08am
StockTexts @StockTexts
$CLSN Celsion Corporation SEC Filing: Form 10-Q https://t.co/hWtjetCbEw
August 14th 2018, 9:08am
Stock_News_Now @Stock_News_Now
$CLSN: New SEC Filing for CLSN: Form 8-K (No. 0001493152-18-011626): https://t.co/UFyfNwWAF4
August 14th 2018, 9:08am
sep_sal @sep_sal
RT @MarketCurrents: Celsion net loss widens in Q2 https://t.co/WoJNqjwCxt #premarket $CLSN
August 14th 2018, 9:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.